Skip to content

Enovis ENOV Current Debt

Current Debt at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$17.46B+25.6%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$1.18B+96.0%
ESAB logo
ESABESAB
$3.79M-78.7%
Artivion logo
ArtivionAORT
$0-100%
Vericel logo
VericelVCEL
$116K0.0%
Globus Medical logo
Globus MedicalGMED

Other financials

Income statement

See full
Revenue$589.2M+5.4%
Gross profit$365.5M+10.0%
Operating income$6.5M+114%
Net income-$8.8M+84.3%
EPS (diluted)-$0.15+84.7%

Balance sheet

See full
Cash & equivalents$33.1M-13.9%
Total debt$1.4B-3.1%
Total equity$1.5B-43.6%
Total assets$3.8B-21.4%

Cash flow

See full
Operating cash flow$24.0M+1,601%
CapEx$52.8M+22.1%
Free cash flow-$28.9M+35.7%

Valuation

See full
Market cap$1.23B-28.4%
Enterprise value$2.55B-17.1%
P/S0.5×-0.3×

Profitability

See full
Gross margin60.5%+4.0pp
Operating margin-47%+18.6pp
Net margin-49.9%+24.1pp
FCF margin-3.1%-1.1pp

Returns & leverage

See full
Return on equity-55.5%-1,722pp
Debt / equity0.9×+0.4×
Current ratio-0.5×

Where this comes from

Reported directly by Enovis in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtCurrent.

The official record: Enovis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Enovis's current debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Enovis's current debt?
Enovis (ENOV) reported current debt of $35M in Q1 2026.
How has Enovis's current debt changed year-over-year?
Enovis's current debt increased by 74.8% year-over-year, from $20.03M to $35M.
What is the long-term trend for Enovis's current debt?
Over 5 years (2020 to 2025), Enovis's current debt has grown at a 5.3% compound annual growth rate (CAGR), from $27.07M to $35M.
What does current debt mean?
The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.